Nova Leap Health Corp (NLH) — Capital Reinvestment Ratio
Latest as of March 2023:
0.10x
Nova Leap Health Corp (NLH) has a Capital Reinvestment Ratio of 0.10x as of March 2023, meaning it reinvests 0% of its operating cash flow (CA$294.33K) in capital expenditures (CA$27.99K). See NLH free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.10x
Capex / Operating Cash Flow
Operating Cash Flow
CA$294.33K
CAD
Capital Expenditures
CA$27.99K
CAD
Data as of
Mar 2023
Most recent filing
Nova Leap Health Corp Capital Reinvestment Ratio (2019–2024)
This chart tracks Nova Leap Health Corp's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Nova Leap Health Corp (2019–2024)
Year-by-year Capital Reinvestment Ratio for Nova Leap Health Corp from 2019 to 2024. For live market cap and broader valuation context, see Nova Leap Health Corp market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.02x | CA$1.39 Million | CA$25.00K | ▲ +38.6% |
| 2023 | 0.01x | CA$2.15 Million | CA$27.99K | ▼ -81.4% |
| 2022 | 0.07x | CA$1.02 Million | CA$71.24K | ▲ +113.6% |
| 2021 | 0.03x | CA$2.18 Million | CA$71.24K | ▲ +1365.2% |
| 2020 | 0.00x | CA$3.01 Million | CA$6.72K | ▼ -91.2% |
| 2019 | 0.03x | CA$613.80K | CA$15.48K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow